| 1 |
33579790 |
10.1136/gutjnl-2020-322935 |
2022 |
Oncogenetic landscape of lymphomagenesis in coeliac disease. |
TNFAIP3 |
| 2 |
34494161 |
10.1007/s00428-021-03186-3 |
2022 |
Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin. |
TNFAIP3 |
| 3 |
34560683 |
10.1097/PAS.0000000000001813 |
2022 |
A Comprehensive Clinicopathologic and Molecular Study of 19 Primary Effusion Lymphomas in HIV-infected Patients. |
TNFAIP3 |
| 4 |
34605949 |
10.1007/s00277-021-04671-0 |
2022 |
Characterization of molecular genetics and clinicopathology in thymic MALT lymphoma. |
TNFAIP3 |
| 5 |
34664256 |
10.1111/bjh.17894 |
2022 |
Tracking the evolution of untreated high-intermediate/high-risk diffuse large B-cell lymphoma by circulating tumour DNA. |
TNFAIP3 |
| 6 |
34840214 |
10.1272/jnms.JNMS.2022_89-305 |
2022 |
Clinicopathologic Characteristics and A20 Mutation in Primary Thyroid Lymphoma. |
TNFAIP3 |
| 7 |
34853447 |
10.1038/s41418-021-00908-7 |
2022 |
Bcl-3 promotes TNF-induced hepatocyte apoptosis by regulating the deubiquitination of RIP1. |
TNFAIP3 |
| 8 |
34952945 |
10.1038/s41379-021-01002-6 |
2022 |
Genomic landscape of Epstein-Barr virus-positive extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue. |
TNFAIP3 |
| 9 |
35030632 |
10.1182/bloodadvances.2021006410 |
2022 |
Distinct clinical and genetic features of hepatitis B virus-associated follicular lymphoma in Chinese patients. |
TNFAIP3 |
| 10 |
35075971 |
10.1080/10428194.2021.2010060 |
2022 |
Circulating tumor DNA in primary mediastinal large B-cell lymphoma versus classical Hodgkin lymphoma: a retrospective study. |
TNFAIP3 |
| 11 |
35089437 |
10.1007/s00018-022-04139-y |
2022 |
A20 undermines alternative NF-κB activity and expression of anti-apoptotic genes in Helicobacter pylori infection. |
TNFAIP3 |
| 12 |
35099607 |
10.1007/s00018-022-04154-z |
2022 |
A20 and ABIN-1 cooperate in balancing CBM complex-triggered NF-κB signaling in activated T cells. |
TNFAIP3 |
| 13 |
35236331 |
10.1186/s12885-022-09237-5 |
2022 |
Prognostic mutational subtyping in de novo diffuse large B-cell lymphoma. |
TNFAIP3 |
| 14 |
35267569 |
10.3390/cancers14051264 |
2022 |
The Biology of Ocular Adnexal Marginal Zone Lymphomas. |
TNFAIP3 |
| 15 |
35490943 |
10.1016/j.jbspin.2022.105390 |
2022 |
Lack of association between the TNFAIP3 rs2230926 variant and rheumatoid arthritis-associated lymphoma. |
TNFAIP3 |
| 16 |
35937947 |
10.1155/2022/6441139 |
2022 |
Genomic Mutation Landscape of Primary Breast Lymphoma: Next-Generation Sequencing Analysis. |
TNFAIP3 |
| 17 |
36001451 |
10.1097/PAS.0000000000001956 |
2022 |
Targeted Mutational Profiling Reveals Clonal Relationships in Metachronous Occurrence of Classic Hodgkin and Mediastinal Large B-Cell Lymphomas. |
TNFAIP3 |
| 18 |
32079702 |
10.3324/haematol.2019.237719 |
2021 |
Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study. |
TNFAIP3 |
| 19 |
32785655 |
10.1182/blood.2019004713 |
2021 |
Identification of MALT1 feedback mechanisms enables rational design of potent antilymphoma regimens for ABC-DLBCL. |
TNFAIP3 |
| 20 |
32808859 |
10.1080/10799893.2020.1808678 |
2021 |
Regulation of cell activation by A20 through STAT signaling in acute lymphoblastic leukemia. |
TNFAIP3 |
| 21 |
32961552 |
10.1182/blood.2020007507 |
2021 |
Mutational landscape of gray zone lymphoma. |
TNFAIP3 |
| 22 |
33263441 |
10.1080/17474086.2021.1856652 |
2021 |
Development of molecular intervention strategies for B-cell lymphoma. |
TNFAIP3 |
| 23 |
33311649 |
10.1038/s41379-020-00720-7 |
2021 |
Targeted massively parallel sequencing of mature lymphoid neoplasms: assessment of empirical application and diagnostic utility in routine clinical practice. |
TNFAIP3 |
| 24 |
33544565 |
10.1097/PAS.0000000000001658 |
2021 |
Immunophenotypic Spectrum and Genomic Landscape of Refractory Celiac Disease Type II. |
TNFAIP3 |
| 25 |
33724154 |
10.1080/21505594.2021.1899674 |
2021 |
Pathogenicity and virulence of Japanese encephalitis virus: Neuroinflammation and neuronal cell damage. |
TNFAIP3 |
| 26 |
33814335 |
10.1016/j.clml.2021.02.010 |
2021 |
A Case of EBV-Negative Aggressive NK-cell Leukemia: Use of Next-Generation Sequencing in Demystifying a Diagnostic Dilemma and Guiding Clinical Care. |
TNFAIP3 |
| 27 |
33887878 |
10.3892/ijo.2021.5211 |
2021 |
Potential of the tumor‑derived extracellular vesicles carrying the miR‑125b‑5p target TNFAIP3 in reducing the sensitivity of diffuse large B cell lymphoma to rituximab. |
TNFAIP3 |
| 28 |
33933552 |
10.1016/j.canlet.2021.04.017 |
2021 |
The dual roles of A20 in cancer. |
TNFAIP3 |
| 29 |
34021249 |
10.1038/s41375-021-01289-z |
2021 |
Thyroid MALT lymphoma: self-harm to gain potential T-cell help. |
TNFAIP3 |
| 30 |
34201504 |
10.3390/cancers13133131 |
2021 |
Deregulated miRNAs Contribute to Silencing of B-Cell Specific Transcription Factors and Activation of NF-κB in Classical Hodgkin Lymphoma. |
TNFAIP3 |
| 31 |
34203889 |
10.3390/cancers13122993 |
2021 |
Genetic Characterization and Clinical Features of <i>Helicobacter pylori</i> Negative Gastric Mucosa-Associated Lymphoid Tissue Lymphoma. |
TNFAIP3 |
| 32 |
34312841 |
10.1111/bjh.17719 |
2021 |
Liquid biopsy: a non-invasive approach for Hodgkin lymphoma genotyping. |
TNFAIP3 |
| 33 |
34405005 |
10.7150/jca.60390 |
2021 |
Serial surveillance by circulating tumor DNA profiling after chimeric antigen receptor T therapy for the guidance of r/r diffuse large B cell lymphoma precise treatment. |
TNFAIP3 |
| 34 |
34447369 |
10.3389/fimmu.2021.671755 |
2021 |
Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management. |
TNFAIP3 |
| 35 |
34526012 |
10.1186/s12935-021-02191-5 |
2021 |
TNFAIP3 mutation may be associated with favorable overall survival for patients with T-cell lymphoma. |
TNFAIP3 |
| 36 |
34558064 |
10.1111/bjh.17824 |
2021 |
Retrospective analyses of other iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with rheumatic diseases. |
TNFAIP3 |
| 37 |
35008340 |
10.3390/cancers14010176 |
2021 |
Recent Advances in the Genetic of MALT Lymphomas. |
TNFAIP3 |
| 38 |
35528192 |
10.1158/2767-9764.crc-21-0022 |
2021 |
The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways. |
TNFAIP3 |
| 39 |
31807922 |
10.1007/s00428-019-02691-w |
2020 |
Subsequent development of histiocytic sarcoma and follicular lymphoma: cytogenetics and next-generation sequencing analyses provide evidence for transdifferentiation of early common lymphoid precursor-a case report and review of literature. |
TNFAIP3 |
| 40 |
31948699 |
10.1016/j.annpat.2019.12.006 |
2020 |
[Low-grade dural extranodal marginal zone lymphoma]. |
TNFAIP3 |
| 41 |
32012328 |
10.1002/hon.2718 |
2020 |
High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas. |
TNFAIP3 |
| 42 |
32059783 |
10.1016/j.cell.2020.01.029 |
2020 |
Lymphoma Driver Mutations in the Pathogenic Evolution of an Iconic Human Autoantibody. |
TNFAIP3 |
| 43 |
32299816 |
10.1158/1078-0432.CCR-19-4137 |
2020 |
A20 and RBX1 Regulate Brentuximab Vedotin Sensitivity in Hodgkin Lymphoma Models. |
TNFAIP3 |
| 44 |
32316399 |
10.3390/cancers12040986 |
2020 |
Identifying Genetic Lesions in Ocular Adnexal Extranodal Marginal Zone Lymphomas of the MALT Subtype by Whole Genome, Whole Exome and Targeted Sequencing. |
TNFAIP3 |
| 45 |
32443356 |
10.1097/MD.0000000000020232 |
2020 |
Genetic heterogeneity of pediatric systemic lupus erythematosus with lymphoproliferation. |
TNFAIP3 |
| 46 |
32565964 |
10.3892/ol.2020.11552 |
2020 |
Comprehensive characterization of driver genes in diffuse large B cell lymphoma. |
TNFAIP3 |
| 47 |
32738175 |
10.1002/hon.2784 |
2020 |
Targeted next-generation sequencing reveals molecular heterogeneity in non-chronic lymphocytic leukemia clonal B-cell lymphocytosis. |
TNFAIP3 |
| 48 |
33045225 |
10.1016/j.humpath.2020.09.014 |
2020 |
The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma. |
TNFAIP3 |
| 49 |
33139544 |
10.1073/pnas.2014470117 |
2020 |
Essential role of the linear ubiquitin chain assembly complex and TAK1 kinase in A20 mutant Hodgkin lymphoma. |
TNFAIP3 |
| 50 |
33154951 |
10.3389/fonc.2020.591577 |
2020 |
Genetic and Non-Genetic Mechanisms of Resistance to BCR Signaling Inhibitors in B Cell Malignancies. |
TNFAIP3 |
| 51 |
30211726 |
10.1097/PAS.0000000000001154 |
2019 |
Cyclin D1-positive Mediastinal Large B-Cell Lymphoma With Copy Number Gains of CCND1 Gene: A Study of 3 Cases With Nonmediastinal Disease. |
TNFAIP3 |
| 52 |
30488325 |
10.1007/s00277-018-3565-5 |
2019 |
Primary hepatic marginal B cell lymphoma of mucosa-associated lymphoid tissue (MALT) and non-alcoholic steatohepatitis (NASH): more than a coincidence? |
TNFAIP3 |
| 53 |
30738453 |
10.7534/j.issn.1009-2137.2019.01.015 |
2019 |
[Correlation of EBV Infection with Expression of TNF-α-Inducing Protein 3 Gene and A20 Protein in Hodgkin's Lmphoma]. |
TNFAIP3 |
| 54 |
31140551 |
10.1093/ajcp/aqz041 |
2019 |
Activation of the NF-κB Pathway and Heterozygous Deletion of TNFAIP3 (A20) Confer Superior Survival in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type. |
TNFAIP3 |
| 55 |
31320741 |
10.1038/s41598-019-46906-1 |
2019 |
Systematic Review of Somatic Mutations in Splenic Marginal Zone Lymphoma. |
TNFAIP3 |
| 56 |
31378966 |
10.1002/ajh.25600 |
2019 |
Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network. |
TNFAIP3 |
| 57 |
31403034 |
10.3389/fonc.2019.00683 |
2019 |
Comprehensive Genomic Profiling of EBV-Positive Diffuse Large B-cell Lymphoma and the Expression and Clinicopathological Correlations of Some Related Genes. |
TNFAIP3 |
| 58 |
31444033 |
10.1016/j.jaut.2019.102317 |
2019 |
Genetic contributors and soluble mediators in prediction of autoimmune comorbidity. |
TNFAIP3 |
| 59 |
31534975 |
10.1155/2019/6728694 |
2019 |
TNFAIP3 Gene Polymorphisms in Three Common Autoimmune Diseases: Systemic Lupus Erythematosus, Rheumatoid Arthritis, and Primary Sjogren Syndrome-Association with Disease Susceptibility and Clinical Phenotypes in Italian Patients. |
TNFAIP3 |
| 60 |
31816062 |
10.1182/bloodadvances.2019001012 |
2019 |
Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion. |
TNFAIP3 |
| 61 |
28296250 |
10.1111/ajco.12672 |
2018 |
Different genetic alteration of A20 in a Sézary syndrome case with Vα2-Jα22 T cell clone. |
TNFAIP3 |
| 62 |
29380463 |
10.1002/gcc.22524 |
2018 |
Clinicopathologic implications of TNFAIP3/A20 deletions in extranodal NK/T-cell lymphoma. |
TNFAIP3 |
| 63 |
29463935 |
10.18926/AMO/55659 |
2018 |
A20 (TNFAIP3) Alterations in Primary Intestinal Diffuse Large B-cell Lymphoma. |
TNFAIP3 |
| 64 |
29674500 |
10.3324/haematol.2018.191601 |
2018 |
Novel <i>GPR34</i> and <i>CCR6</i> mutation and distinct genetic profiles in MALT lymphomas of different sites. |
TNFAIP3 |
| 65 |
29695787 |
10.1038/s41556-018-0084-5 |
2018 |
Loss of KLHL6 promotes diffuse large B-cell lymphoma growth and survival by stabilizing the mRNA decay factor roquin2. |
TNFAIP3 |
| 66 |
29765142 |
10.1038/s41379-018-0064-0 |
2018 |
Targeted deep sequencing of gastric marginal zone lymphoma identified alterations of TRAF3 and TNFAIP3 that were mutually exclusive for MALT1 rearrangement. |
TNFAIP3 |
| 67 |
29891112 |
10.1016/j.critrevonc.2018.05.010 |
2018 |
Molecular analysis in liquid biopsies for diagnostics of primary central nervous system lymphoma: Review of literature and future opportunities. |
TNFAIP3 |
| 68 |
30087457 |
10.1038/s41374-018-0096-6 |
2018 |
Novel cell enrichment technique for robust genetic analysis of archival classical Hodgkin lymphoma tissues. |
TNFAIP3 |
| 69 |
30214692 |
10.18632/oncotarget.26080 |
2018 |
Correction: The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in <i>TNFAIP3</i> followed by mutations in <i>TBL1XR1</i> and <i>CREBBP</i>. |
TNFAIP3 |
| 70 |
30301877 |
10.1038/s41408-018-0130-3 |
2018 |
Loss of TNFAIP3 enhances MYD88<sub>L265P</sub>-driven signaling in non-Hodgkin lymphoma. |
TNFAIP3 |
| 71 |
30662920 |
10.1155/2018/6923213 |
2018 |
TNFAIP3 F127C Coding Variation in Greek Primary Sjogren's Syndrome Patients. |
TNFAIP3 |
| 72 |
27297871 |
10.1111/his.13015 |
2017 |
Recurrent mutations in genes involved in nuclear factor-κB signalling in nodal marginal zone lymphoma-diagnostic and therapeutic implications. |
TNFAIP3 |
| 73 |
28073005 |
10.1016/j.ccell.2016.12.003 |
2017 |
Simultaneous Inhibition of PI3Kδ and PI3Kα Induces ABC-DLBCL Regression by Blocking BCR-Dependent and -Independent Activation of NF-κB and AKT. |
TNFAIP3 |
| 74 |
28152507 |
10.18632/oncotarget.14928 |
2017 |
The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP. |
TNFAIP3 |
| 75 |
28153771 |
10.1016/j.ebiom.2017.01.027 |
2017 |
B-cell Function Gene Mutations in Diffuse Large B-cell Lymphoma: A Retrospective Cohort Study. |
TNFAIP3 |
| 76 |
28178345 |
10.1371/journal.pone.0171221 |
2017 |
PI3Kδ inhibitor idelalisib in combination with BTK inhibitor ONO/GS-4059 in diffuse large B cell lymphoma with acquired resistance to PI3Kδ and BTK inhibitors. |
TNFAIP3 |
| 77 |
28189285 |
10.1016/j.prp.2016.11.001 |
2017 |
Mutation analysis of tumor necrosis factor alpha-induced protein 3 gene in Hodgkin lymphoma. |
TNFAIP3 |
| 78 |
28288707 |
10.1016/j.beha.2016.09.002 |
2017 |
MALT lymphoma: Genetic abnormalities, immunological stimulation and molecular mechanism. |
TNFAIP3 |
| 79 |
28479318 |
10.1016/j.jid.2017.04.010 |
2017 |
Identification of Somatic Mutations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type by Massive Parallel Sequencing. |
TNFAIP3 |
| 80 |
28682481 |
10.1002/path.4933 |
2017 |
Significant association between TNFAIP3 inactivation and biased immunoglobulin heavy chain variable region 4-34 usage in mucosa-associated lymphoid tissue lymphoma. |
TNFAIP3 |
| 81 |
28751561 |
10.3324/haematol.2016.160192 |
2017 |
Exome sequencing identifies recurrent <i>BCOR</i> alterations and the absence of <i>KLF2</i>, <i>TNFAIP3</i> and <i>MYD88</i> mutations in splenic diffuse red pulp small B-cell lymphoma. |
TNFAIP3 |
| 82 |
28892161 |
10.1002/path.4982 |
2017 |
A gene is known by the company it keeps: enrichment of TNFAIP3 gene aberrations in MALT lymphomas expressing IGHV4-34 antigen receptors. |
TNFAIP3 |
| 83 |
29033545 |
10.2147/DDDT.S135993 |
2017 |
Downregulation of A20 increases the cytotoxicity of IFN-γ in hepatocellular carcinoma cells. |
TNFAIP3 |
| 84 |
26338037 |
10.1136/annrheumdis-2015-207731 |
2016 |
Germline variation of TNFAIP3 in primary Sjögren's syndrome-associated lymphoma. |
TNFAIP3 |
| 85 |
26437781 |
10.1038/leu.2015.267 |
2016 |
A20 targets caspase-8 and FADD to protect HTLV-I-infected cells. |
TNFAIP3 |
| 86 |
26518771 |
10.1007/s13277-015-4322-1 |
2016 |
Higher incidence of the SNP Met 788 Ile in the coding region of A20 in diffuse large B cell lymphomas. |
TNFAIP3 |
| 87 |
26650888 |
10.1002/gcc.22331 |
2016 |
Recurrent somatic loss of TNFRSF14 in classical Hodgkin lymphoma. |
TNFAIP3 |
| 88 |
26679293 |
10.1111/sji.12405 |
2016 |
Low Protein A20 in Minor Salivary Glands is Associated with Lymphoma in Primary Sjögren's Syndrome. |
TNFAIP3 |
| 89 |
26752547 |
10.1097/PAS.0000000000000592 |
2016 |
Frequent MYD88 L265P and CD79B Mutations in Primary Breast Diffuse Large B-Cell Lymphoma. |
TNFAIP3 |
| 90 |
26780579 |
10.1111/ajt.13558 |
2016 |
EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features. |
TNFAIP3 |
| 91 |
26819451 |
10.1158/1078-0432.CCR-15-2305 |
2016 |
Next-Generation Sequencing in Diffuse Large B-Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study. |
TNFAIP3 |
| 92 |
26986245 |
10.3892/or.2016.4662 |
2016 |
Development of a high-resolution melting method for the screening of TNFAIP3 gene mutations. |
TNFAIP3 |
| 93 |
27050077 |
10.18632/oncotarget.8537 |
2016 |
Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphoma. |
TNFAIP3 |
| 94 |
27221964 |
10.1016/j.semcancer.2016.05.001 |
2016 |
NF-κB deregulation in Hodgkin lymphoma. |
TNFAIP3 |
| 95 |
27248180 |
10.18632/oncotarget.9678 |
2016 |
The genetic landscape of dural marginal zone lymphomas. |
TNFAIP3 |
| 96 |
27349720 |
10.3892/or.2016.4899 |
2016 |
PMA/IONO affects diffuse large B-cell lymphoma cell growth through upregulation of A20 expression. |
TNFAIP3 |
| 97 |
27435953 |
10.1111/ajco.12577 |
2016 |
A20 SNP rs77191406 may be related to secondary cancer for rheumatoid arthritis and systemic lupus erythematosus patients. |
TNFAIP3 |
| 98 |
27452667 |
10.1016/j.semcancer.2016.07.003 |
2016 |
MALT lymphoma: A paradigm of NF-κB dysregulation. |
TNFAIP3 |
| 99 |
27551157 |
10.1084/jem.20151065 |
2016 |
NKT sublineage specification and survival requires the ubiquitin-modifying enzyme TNFAIP3/A20. |
TNFAIP3 |
| 100 |
27566587 |
10.18632/oncotarget.11548 |
2016 |
Recurrent mutations in NF-κB pathway components, KMT2D, and NOTCH1/2 in ocular adnexal MALT-type marginal zone lymphomas. |
TNFAIP3 |
Datasets
Models
